Mitochondrial creatine kinase in human health and disease

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1762, Issue 2, 2006, Pages 164-180

  Schlattner, Uwe ^a   Tokarska Schlattner, Malgorzata ^a   Wallimann, Theo ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Apoptosis; Cardiomyopathy; Crystalline intra mitochondrial inclusion; Energy metabolism; Neurodegenerative disease; Oxidative damage

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; CALCIUM; CREATINE PHOSPHATE; MITOCHONDRIAL CREATINE KINASE; MITOCHONDRIAL ENZYME; UNCLASSIFIED DRUG;

APOPTOSIS; CARDIOMYOPATHY; CELL ENERGY; CELL MEMBRANE PERMEABILITY; CYTOSOL; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; ENZYME MECHANISM; GENE EXPRESSION; HOMEOSTASIS; HUMAN; ISCHEMIA; MITOCHONDRION; NECROSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVIEW; UPREGULATION;

ANIMALS; CREATINE KINASE; DISEASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEALTH; HUMANS; MITOCHONDRIA; UP-REGULATION;

EID: 29344445187     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2005.09.004     Document Type: Review

References (254)

1. U. Schlattner, M. Forstner, M. Eder, O. Stachowiak, K. Fritz-Wolf, and T. Wallimann Functional aspects of the X-ray structure of mitochondrial creatine kinase: a molecular physiology approach Mol. Cell. Biochem. 184 1998 125 140
2. K. Nicolay, F.A. van Dorsten, T. Reese, M.J. Kruiskamp, J.F. Gellerich, and C.J. van Echteld In situ measurements of creatine kinase flux by NMR. The lessons from bioengineered mice Mol. Cell. Biochem. 184 1998 195 208
3. R. Ventura-Clapier, A. Kuznetsov, V. Veksler, E. Boehm, and K. Anflous Functional coupling of creatine kinases in muscles: species and tissue specificity Mol. Cell. Biochem. 184 1998 231 247
4. W. Ellington Evolution and physiological roles of phosphagen systems Annu. Rev. Physiol. 63 2001 289 325
5. P.P. Dzeja, and A. Terzic Phosphotransfer networks and cellular energetics J. Exp. Biol. 206 2003 2039 2047
6. M. Dolder, B. Walzel, O. Speer, U. Schlattner, and T. Wallimann Inhibition of the mitochondrial permeability transition by creatine kinase substrates, requirement for microcompartmentation J. Biol. Chem. 278 2003 17760 17766
7. T. Andrienko, A.V. Kuznetsov, T. Kaambre, Y. Usson, A. Orosco, F. Appaix, T. Tiivel, P. Sikk, M. Vendelin, R. Margreiter, and V.A. Saks Metabolic consequences of functional complexes of mitochondria, myofibrils and sarcoplasmic reticulum in muscle cells J. Exp. Biol. 206 2003 2059 2072
8. M.Y. Vyssokikh, and D. Brdiczka The function of complexes between the outer mitochondrial membrane pore (VDAC) and the adenine nucleotide translocase in regulation of energy metabolism and apoptosis Acta Biochim. Pol. 50 2003 389 404
9. U. Schlattner, and T. Wallimann Molecular structure and function of mitochondrial creatine kinases V.N. Uversky Creatine Kinase- Biochemistry, Physiology, Structure and Function 2005 Nova Science Publishers New York, USA
10. M. McLeish, G. Kenyon, and M. Cox Relating structure to mechanism in creatine kinase Crit. Rev. Biochem. Mol. Biol. 40 2005 1 20
11. S.A. Kuby, L. Noda, and H.A. Lardy Adenosinetriphosphate-creatine transphosphorylase: I. Isolation of the crystalline enzyme from rabbit muscle J. Biol. Chem. 209 1954 191 201
12. M.E. Eppenberger, H.M. Eppenberger, and N.O. Kaplan Evolution of creatine kinase Nature 214 1967 239 241
13. W.E. Jacobus, and A.L. Lehninger Creatine kinase of rat heart mitochondria. Coupling of creatine phosphorylation to electron transport J. Biol. Chem. 248 1973 4803 4810
14. J. Schlegel, M. Wyss, U. Schurch, T. Schnyder, A. Quest, G. Wegmann, H.M. Eppenberger, and T. Wallimann Mitochondrial creatine kinase from cardiac muscle and brain are two distinct isoenzymes but both form octameric molecules J. Biol. Chem. 263 1988 16963 16969
15. T. Wallimann, and W. Hemmer Creatine kinase in non-muscle tissues and cells Mol. Cell. Biochem. 133-134 1994 193 220
16. P. Kaldis, M. Stolz, M. Wyss, E. Zanolla, B. Rothen-Rutishauser, T. Vorherr, and T. Wallimann Identification of two distinctly localized mitochondrial creatine kinase isoenzymes in spermatozoa J. Cell Sci. 109 1996 2079 2088
17. J. Boero, W. Qin, J. Cheng, T.A. Woolsey, A.W. Strauss, and Z. Khuchua Restricted neuronal expression of ubiquitous mitochondrial creatine kinase: changing patterns in development and with increased activity Mol. Cell. Biochem. 244 2003 69 76
18. T. Wallimann, M. Wyss, D. Brdiczka, K. Nicolay, and H.M. Eppenberger Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis Biochem J. 281 1992 21 40
19. V.A. Saks, R. Ventura-Clapier, and M.K. Aliev Metabolic control and metabolic capacity: two aspects of creatine kinase functioning in the cells Biochim. Biophys. Acta 1274 1996 81 88
20. M. Wyss, and R. Kaddurah-Daouk Creatine and creatinine metabolism Physiol. Rev. 80 2000 1107 1213
21. V.A. Saks, A.V. Kuznetsov, M. Vendelin, K. Guerrero, L. Kay, and E.K. Seppet Functional coupling as a basic mechanism of feedback regulation of cardiac energy metabolism Mol. Cell. Biochem. 256-257 2004 185 199
22. U. Sauer, and U. Schlattner Inverse metabolic engineering with phosphagen kinase systems improves the cellular energy state Metab. Eng. 6 2004 220 228
23. J.S. Ingwall Transgenesis and cardiac energetics: new insights into cardiac metabolism J. Mol. Cell. Cardiol. 37 2004 613 623
24. J. Ovadi, and P.A. Srere Macromolecular compartmentation and channeling Int. Rev. Cytol. 192 2000 255 280
25. U. Schlattner, and T. Wallimann Metabolite channeling: creatine kinase microcompartments W.J. Lennarz M.D. Lane Encyclopedia of Biological Chemistry 2004 Academic Press New York, USA 646 651
26. S.P. Bessman, and P.J. Geiger Transport of energy in muscle: the phosphorylcreatine shuttle Science 211 1981 448 452
27. V.A. Saks, L.V. Rosenshtraukh, V.N. Smirnov, and E.I. Chazov Role of creatine phosphokinase in cellular function and metabolism Can. J. Physiol. Pharmacol. 56 1978 691 706
28. T. Wallimann 31P-NMR-measured creatine kinase reaction flux in muscle: a caveat! J. Muscle Res. Cell Motil. 17 1996 177 181
29. R.W. Wiseman, and M.J. Kushmerick Phosphorus metabolite distribution in skeletal muscle: quantitative bioenergetics using creatine analogs Mol. Cell. Biochem. 174 1997 23 28
30. P.W. Hochachka Oxygen, homeostasis, and metabolic regulation Adv. Exp. Med. Biol. 475 2000 311 335
31. E.K. Seppet, T. Kaambre, P. Sikk, T. Tiivel, H. Vija, M. Tonkonogi, K. Sahlin, L. Kay, F. Appaix, U. Braun, M. Eimre, and V.A. Saks Functional complexes of mitochondria with Ca,MgATPases of myofibrils and sarcoplasmic reticulum in muscle cells Biochim. Biophys. Acta 1504 2001 379 395
32. V.A. Saks, T. Kaambre, P. Sikk, M. Eimre, E. Orlova, K. Paju, A. Piirsoo, F. Appaix, L. Kay, V. Regitz-Zagrosek, E. Fleck, and E. Seppet Intracellular energetic units in red muscle cells Biochem J. 356 2001 643 657
33. A. Kaasik, V. Veksler, E. Boehm, M. Novotova, A. Minajeva, and R. Ventura-Clapier Energetic crosstalk between organelles: architectural integration of energy production and utilization Circ. Res. 89 2001 153 159
34. F. Joubert, J.L. Mazet, P. Mateo, and J.A. Hoerter 31P NMR detection of subcellular creatine kinase fluxes in the perfused rat heart: contractility modifies energy transfer pathways J. Biol. Chem. 277 2002 18469 18476
35. P.P. Dzeja, R. Bortolon, C. Perez-Terzic, E.L. Holmuhamedov, and A. Terzic Energetic communication between mitochondria and nucleus directed by catalyzed phosphotransfer Proc. Natl. Acad. Sci. U. S. A. 99 2002 10156 10161
36. A. Kaasik, V. Veksler, E. Boehm, M. Novotova, and R. Ventura-Clapier From energy store to energy flux: a study in creatine kinase-deficient fast skeletal muscle FASEB J. 17 2003 708 710
37. K. Steeghs, A. Benders, F. Oerlemans, A. de Haan, A. Heerschap, W. Ruitenbeek, C. Jost, J. van Deursen, B. Perryman, D. Pette, M. Bruckwilder, J. Koudijs, P. Jap, J. Veerkamp, and B. Wieringa Altered Ca2+ responses in muscles with combined mitochondrial and cytosolic creatine kinase deficiencies Cell 89 1997 93 103
38. A.J. de Groof, J.A. Fransen, R.J. Errington, P.H. Willems, B. Wieringa, and W.J. Koopman The creatine kinase system is essential for optimal refill of the sarcoplasmic reticulum Ca2+ store in skeletal muscle J. Biol. Chem. 277 2002 5275 5284
39. F.A. Dorsten, M. Wyss, T. Wallimann, and K. Nicolay Activation of sea-urchin sperm motility is accompanied by an increase in the creatine kinase exchange flux Biochem J. 325 1997 411 416
40. P. Kaldis, G. Kamp, T. Piendl, and T. Wallimann Functions of creatine kinase isoenzymes in spermatozoa Adv. Dev. Biol. 5 1997 275 312
41. P.P. Dzeja, R.J. Zeleznikar, and N.D. Goldberg Suppression of creatine kinase-catalyzed phosphotransfer results in increased phosphoryl transfer by adenylate kinase in intact skeletal muscle J. Biol. Chem. 271 1996 12847 12851
42. P.P. Dzeja, A. Terzic, and B. Wieringa Phosphotransfer dynamics in skeletal muscle from creatine kinase gene-deleted mice Mol. Cell. Biochem. 256-257 2004 13 27
43. F. Joubert, J.A. Hoerter, and J.L. Mazet Discrimination of cardiac subcellular creatine kinase fluxes by NMR spectroscopy: a new method of analysis Biophys. J. 81 2001 2995 3004
44. M.E. Bollard, A.J. Murray, K. Clarke, J.K. Nicholson, and J.L. Griffin A study of metabolic compartmentation in the rat heart and cardiac mitochondria using high-resolution magic angle spinning 1H NMR spectroscopy FEBS Lett. 553 2003 73 78
45. G.J. Kemp, D.N. Manners, J.F. Clark, M.E. Bastin, and G.K. Radda Theoretical modelling of some spatial and temporal aspects of the mitochondrion/creatine kinase/myofibril system in muscle Mol. Cell. Biochem. 184 1998 249 289
46. V. Saks, A. Kuznetsov, T. Andrienko, Y. Usson, F. Appaix, K. Guerrero, T. Kaambre, P. Sikk, M. Lemba, and M. Vendelin Heterogeneity of ADP diffusion and regulation of respiration in cardiac cells Biophys. J. 84 2003 3436 3456
47. M. Vendelin, M. Lemba, and V.A. Saks Analysis of functional coupling: mitochondrial creatine kinase and adenine nucleotide translocase Biophys. J. 87 2004 696 713
48. I.E. Scheffler Mitochondria make a come back Adv. Drug Delivery Rev. 49 2001 3 26
49. D.D. Newmeyer, and S. Ferguson-Miller Mitochondria: releasing power for life and unleashing the machineries of death Cell 112 2003 481 490
50. G. Wegmann, R. Huber, E. Zanolla, H.M. Eppenberger, and T. Wallimann Differential expression and localization of brain-type and mitochondrial creatine kinase isoenzymes during development of the chicken retina: Mi-CK as a marker for differentiation of photoreceptor cells Differentiation 46 1991 77 87
51. M. Kottke, T. Wallimann, and D. Brdiczka Dual electron microscopic localization of mitochondrial creatine kinase in brain mitochondria Biochem. Med. Metab. Biol. 51 1994 105 117
52. T.G. Frey, and C.A. Mannella The internal structure of mitochondria Trends Biochem. Sci. 25 2000 319 324
53. K. Fritz-Wolf, T. Schnyder, T. Wallimann, and W. Kabsch Structure of mitochondrial creatine kinase Nature 381 1996 341 345
54. C.A. Mannella, D.R. Pfeiffer, P.C. Bradshaw, B. Moraru II, L.M. Slepchenko, C.E. Loew, K. Hsieh, and M. Buttle Topology of the mitochondrial inner membrane: dynamics and bioenergetic implications IUBMB Life 52 2001 93 100
55. D. Brdiczka, G. Knoll, I. Riesinger, U. Weiler, G. Klug, R. Benz, and J. Krause Microcompartmentation at the mitochondrial surface: its function in metabolic regulation Adv. Exp. Med. Biol. 194 1986 55 69
56. F.N. Gellerich, and W. Kunz Cause and consequences of dynamic compartmentation of adenine nucleotides in the mitochondrial intermembrane space in respect to exchange of energy rich phosphates between cytosol and mitochondria Biomed. Biochim. Acta 46 1987 S545 S548
57. F.N. Gellerich, S. Trumbeckaite, J.R. Opalka, E. Seppet, H.N. Rasmussen, C. Neuhoff, and S. Zierz Function of the mitochondrial outer membrane as a diffusion barrier in health and diseases Biochem. Soc Trans. 28 2000 164 169
58. F.N. Gellerich, F.D. Laterveer, S. Zierz, and K. Nicolay The quantitation of ADP diffusion gradients across the outer membrane of heart mitochondria in the presence of macromolecules Biochim. Biophys. Acta 1554 2002 48 56
59. C.R. Hackenbrock Chemical and physical fixation of isolated mitochondria in low-energy and high-energy states Proc. Natl. Acad. Sci. U. S. A. 61 1968 598 605
60. G. Knoll, and D. Brdiczka Changes in freeze-fractured mitochondrial membranes correlated to their energetic state. Dynamic interactions of the boundary membranes Biochim. Biophys. Acta 733 1983 102 110
61. K. Bucheler, V. Adams, and D. Brdiczka Localization of the ATP/ADP translocator in the inner membrane and regulation of contact sites between mitochondrial envelope membranes by ADP. A study on freeze-fractured isolated liver mitochondria Biochim. Biophys. Acta 1056 1991 233 242
62. A.S. Reichert, and W. Neupert Contact sites between the outer and inner membrane of mitochondria-Role in protein transport Biochim. Biophys. Acta 1592 2002 41 49
63. L. Pon, T. Moll, D. Vestweber, B. Marshallsay, and G. Schatz Protein import into mitochondria: ATP-dependent protein translocation activity in a submitochondrial fraction enriched in membrane contact sites and specific proteins J. Cell Biol. 109 1989 2603 2616
64. G. Beutner, A. Ruck, B. Riede, and D. Brdiczka Complexes between hexokinase, mitochondrial porin and adenylate translocator in brain: regulation of hexokinase, oxidative phosphorylation and permeability transition pore Biochem. Soc Trans. 25 1997 151 157
65. G. Beutner, A. Ruck, B. Riede, W. Welte, and D. Brdiczka Complexes between kinases, mitochondrial porin and adenylate translocator in rat brain resemble the permeability transition pore FEBS Lett. 396 1996 189 195
66. I. Marzo, C. Brenner, N. Zamzami, S.A. Susin, G. Beutner, D. Brdiczka, R. Remy, Z.H. Xie, J.C. Reed, and G. Kroemer The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins J. Exp. Med. 187 1998 1261 1271
67. K. Woodfield, A. Ruck, D. Brdiczka, and A.P. Halestrap Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition Biochem. J. 336 1998 287 290
68. U. Schlattner, F. Gehring, N. Vernoux, M. Tokarska-Schlattner, D. Neumann, O. Marcillat, C. Vial, and T. Wallimann C-terminal lysines determine phospholipid interaction of sarcomeric mitochondrial creatine kinase J. Biol. Chem. 279 2004 24334 24342
69. M. Crompton Mitochondrial intermembrane junctional complexes and their role in cell death J. Physiol. 529 Pt. 1 2000 11 21
70. L. Milon, P. Meyer, M. Chiadmi, A. Munier, M. Johansson, A. Karlsson, I. Lascu, J. Capeau, J. Janin, and M.L. Lacombe The human nm23-H4 gene product is a mitochondrial nucleoside diphosphate kinase J. Biol. Chem. 275 2000 14264 14272
71. O. McGuinness, N. Yafei, A. Costi, and M. Crompton The presence of two classes of high-affinity cyclosporin A binding sites in mitochondria. Evidence that the minor component is involved in the opening of an inner-membrane Ca(2+)-dependent pore Eur. J. Biochem. 194 1990 671 679
72. C.A. Mannella Conformational changes in the mitochondrial channel protein, VDAC, and their functional implications J. Struct. Biol. 121 1998 207 218
73. M. Vyssokikh, L. Zorova, D. Zorov, G. Heimlich, J. Jurgensmeier, D. Schreiner, and D. Brdiczka The intra-mitochondrial cytochrome c distribution varies correlated to the formation of a complex between VDAC and the adenine nucleotide translocase: this affects Bax-dependent cytochrome c release Biochim. Biophys. Acta 1644 2004 27 36
74. D.R. Green, and G. Kroemer The pathophysiology of mitochondrial cell death Science 305 2004 626 629
75. K. Gottlob, N. Majewski, S. Kennedy, E. Kandel, R.B. Robey, and N. Hay Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase Genes Dev. 15 2001 1406 1418
76. J.M. Bryson, P.E. Coy, K. Gottlob, N. Hay, and R.B. Robey Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death J. Biol. Chem. 277 2002 11392 11400
77. J.G. Pastorino, N. Shulga, and J.B. Hoek Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis J. Biol. Chem. 277 2002 7610 7618
78. H. Azoulay-Zohar, A. Israelson, S. Abu-Hamad, and V. Shoshan-Barmatz In self-defense: hexokinase promotes VDAC closure and prevents mitochondria- mediated apoptotic cell death Biochem J. 377 2004 347 355
79. N. Majewski, V. Nogueira, R.B. Robey, and N. Hay Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases Mol. Cell. Biol. 24 2004 730 740
80. N. Pfanner, and A. Geissler Versatility of the mitochondrial protein import machinery Nat. Rev., Mol. Cell Biol. 2 2001 339 349
81. U. Schlattner, and T. Wallimann Octamers of mitochondrial creatine kinase isoenzymes differ in stability and membrane binding J. Biol. Chem. 275 2000 17314 17320
82. M. Rojo, R. Hovius, R.A. Demel, K. Nicolay, and T. Wallimann Mitochondrial creatine kinase mediates contact formation between mitochondrial membranes J. Biol. Chem. 266 1991 20290 20295
83. U. Schlattner, M. Dolder, T. Wallimann, and M. Tokarska-Schlattner Mitochondrial creatine kinase and mitochondrial outer membrane porin show a direct interaction that is modulated by calcium J. Biol. Chem. 276 2001 48027 48030
84. G. Beutner, A. Ruck, B. Riede, and D. Brdiczka Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases Biochim. Biophys. Acta 1368 1998 7 18
85. Z.A. Khuchua, W. Qin, J. Boero, J. Cheng, R.M. Payne, V.A. Saks, and A.W. Strauss Octamer formation and coupling of cardiac sarcomeric mitochondrial creatine kinase are mediated by charged N-terminal residues J. Biol. Chem. 273 1998 22990 22996
86. O. Speer, N. Back, T. Buerklen, D. Brdiczka, A. Koretsky, T. Wallimann, and O. Eriksson Octameric mitochondrial creatine kinase induces and stabilizes contact sites between the inner and outer membrane Biochem. J. 385 2005 445 450
87. D. Gincel, H. Zaid, and V. Shoshan-Barmatz Calcium binding and translocation by the voltage-dependent anion channel: a possible regulatory mechanism in mitochondrial function Biochem. J. 358 2001 147 155
88. D. Brdiczka, G. Beutner, A. Ruck, M. Dolder, and T. Wallimann The molecular structure of mitochondrial contact sites. Their role in regulation of energy metabolism and permeability transition BioFactors 8 1998 235 242
89. V.A. Saks, A.V. Kuznetsov, V.V. Kupriyanov, M.V. Miceli, and W.E. Jacobus Creatine kinase of rat heart mitochondria. The demonstration of functional coupling to oxidative phosphorylation in an inner membrane-matrix preparation J. Biol. Chem. 260 1985 7757 7764
90. T. Tiivel, L. Kadaya, A. Kuznetsov, T. Kaambre, N. Peet, P. Sikk, U. Braun, R. Ventura-Clapier, V. Saks, and E.K. Seppet Developmental changes in regulation of mitochondrial respiration by ADP and creatine in rat heart in vivo Mol. Cell. Biochem. 208 2000 119 128
91. S.A. Smith, S.J. Montain, G.P. Zientara, and R.A. Fielding Use of phosphocreatine kinetics to determine the influence of creatine on muscle mitochondrial respiration: an in vivo 31P-MRS study of oral creatine ingestion J. Appl. Physiol. 96 2004 2288 2292
92. L. Kay, K. Nicolay, B. Wieringa, V. Saks, and T. Wallimann Direct evidence for the control of mitochondrial respiration by mitochondrial creatine kinase in oxidative muscle cells in situ J. Biol. Chem. 275 2000 6937 6944
93. D. Brdiczka, and T. Wallimann The importance of the outer mitochondrial compartment in regulation of energy metabolism Mol. Cell. Biochem. 133-134 1994 69 83
94. D. Brdiczka Function of the outer mitochondrial compartment in regulation of energy metabolism Biochim. Biophys. Acta 1187 1994 264 269
95. P. Bernardi, L. Scorrano, R. Colonna, V. Petronilli, and F. Di Lisa Mitochondria and cell death. Mechanistic aspects and methodological issues Eur. J. Biochem. 264 1999 687 701
96. A.P. Halestrap, E. Doran, J.P. Gillespie, and A. O'Toole Mitochondria and cell death Biochem. Soc Trans. 28 2000 170 177
97. A.M. Cesura, E. Pinard, R. Schubenel, V. Goetschy, A. Friedlein, H. Langen, P. Polcic, M.A. Forte, P. Bernardi, and J.A. Kemp The voltage-dependent anion channel is the target for a new class of inhibitors of the mitochondrial permeability transition pore J. Biol. Chem. 278 2003 49812 49818
98. P. Bernardi Mitochondrial transport of cations: channels, exchangers, and permeability transition Physiol. Rev. 79 1999 1127 1155
99. X.M. Leverve, and E. Fontaine Role of substrates in the regulation of mitochondrial function in situ IUBMB Life 52 2001 221 229
100. M. Zoratti, I. Szabo, and U. De Marchi Mitochondrial permeability transitions: how many doors to the house? Biochim. Biophys. Acta 1706 2005 40 52
101. J.E. Kokoszka, K.G. Waymire, S.E. Levy, J.E. Sligh, J. Cai, D.P. Jones, G.R. MacGregor, and D.C. Wallace The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore Nature 427 2004 461 465
102. A.P. Halestrap Mitochondrial permeability: dual role for the ADP/ATP translocator? Nature 430 2004 983
103. K. Miller, K. Sharer, J. Suhan, and A.P. Koretsky Expression of functional mitochondrial creatine kinase in liver of transgenic mice Am. J. Physiol. 272 1997 C1193 C1202
104. E. O'Gorman, G. Beutner, M. Dolder, A.P. Koretsky, D. Brdiczka, and T. Wallimann The role of creatine kinase in inhibition of mitochondrial permeability transition FEBS Lett. 414 1997 253 257
105. M. Dolder, S. Wendt, and T. Wallimann Mitochondrial creatine kinase in contact sites: interaction with porin and adenine nucleotide translocase, role in permeability transition and sensitivity to oxidative damage Biol. Signals Recept. 10 2001 93 111
106. E. Hatano, A. Tanaka, A. Kanazawa, S. Tsuyuki, S. Tsunekawa, S. Iwata, R. Takahashi, B. Chance, and Y. Yamaoka Inhibition of tumor necrosis factor-induced apoptosis in transgenic mouse liver expressing creatine kinase Liver Int. 24 2004 384 393
107. M.F. Beal Energetics in the pathogenesis of neurodegenerative diseases Trends Neurosci. 23 2000 298 304
108. S. Raha, and B.H. Robinson Mitochondria, oxygen free radicals, disease and ageing Trends Biochem. Sci. 25 2000 502 508
109. R.S. Sohal, and R. Weindruch Oxidative stress, caloric restriction, and aging Science 273 1996 59 63
110. M.A. Tarnopolsky, and M.F. Beal Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders Ann. Neurol. 49 2001 561 574
111. K. Steeghs, F. Oerlemans, A. de Haan, A. Heerschap, L. Verdoodt, M. de Bie, W. Ruitenbeek, A. Benders, C. Jost, J. van Deursen, P. Tullson, R. Terjung, P. Jap, W. Jacob, D. Pette, and B. Wieringa Cytoarchitectural and metabolic adaptations in muscles with mitochondrial and cytosolic creatine kinase deficiencies Mol. Cell. Biochem. 184 1998 183 194
112. C. Thomas, A.C. Carr, and C.C. Winterbourn Free radical inactivation of rabbit muscle creatinine kinase: catalysis by physiological and hydrolyzed ICRF-187 (ICRF-198) iron chelates Free Radical Res. 21 1994 387 397
113. E.A. Konorev, N. Hogg, and B. Kalyanaraman Rapid and irreversible inhibition of creatine kinase by peroxynitrite FEBS Lett. 427 1998 171 174
114. M. Aksenov, M. Aksenova, D.A. Butterfield, and W.R. Markesbery Oxidative modification of creatine kinase BB in Alzheimer's disease brain J. Neurochem. 74 2000 2520 2527
115. A. Castegna, M. Aksenov, M. Aksenova, V. Thongboonkerd, J. Klein, W. Pierce, R. Booze, W. Markesbery, and D. Butterfield Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain: Part I. creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1 Free Radical Biol. Med. 33 2002 562
116. H.F. Poon, A. Castegna, S.A. Farr, V. Thongboonkerd, B.C. Lynn, W.A. Banks, J.E. Morley, J.B. Klein, and D.A. Butterfield Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain Neuroscience 126 2004 915 926
117. O. Stachowiak, M. Dolder, T. Wallimann, and C. Richter Mitochondrial creatine kinase is a prime target of peroxynitrite-induced modification and inactivation J. Biol. Chem. 273 1998 16694 16699
118. P. Koufen, and G. Stark Free radical induced inactivation of creatine kinase: sites of interaction, protection, and recovery Biochim. Biophys. Acta 1501 2000 44 50
119. P. Koufen, A. Ruck, D. Brdiczka, S. Wendt, T. Wallimann, and G. Stark Free radical-induced inactivation of creatine kinase: influence on the octameric and dimeric states of the mitochondrial enzyme (Mib-CK) Biochem J. 344 Pt. 2 1999 413 417
120. P. Liu, C.E. Hock, R. Nagele, and P.Y. Wong Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats Am. J. Physiol. 272 1997 H2327 H2336
121. M.F. Beal Oxidatively modified proteins in aging and disease Free Radical Biol. Med. 32 2002 797 803
122. C. Richter, M. Schweizer, and P. Ghafourifar Mitochondria, nitric oxide, and peroxynitrite Methods Enzymol. 301 1999 381 393
123. E. Cadenas, and K.J. Davies Mitochondrial free radical generation, oxidative stress, and aging Free Radical Biol. Med. 29 2000 222 230
124. M. Tokarska-Schlattner, T. Wallimann, and U. Schlattner Multiple interference of anthracyclines with mitochondrial creatine kinases: preferential damage of the cardiac isoenzyme and its implications for drug cardiotoxicity Mol. Pharmacol. 61 2002 516 523
125. P. Korge, and K.B. Campbell Iron effects on myocardial enzymes depend on redox state J. Mol. Cell. Cardiol. 26 1994 151 162
126. H. Wolosker, R. Panizzutti, and S. Engelender Inhibition of creatine kinase by S-nitrosoglutathione FEBS Lett. 392 1996 274 276
127. H. Mekhfi, V. Veksler, P. Mateo, V. Maupoil, L. Rochette, and R. Ventura-Clapier Creatine kinase is the main target of reactive oxygen species in cardiac myofibrils Circ. Res. 78 1996 1016 1027
128. S. Wendt, U. Schlattner, and T. Wallimann Differential effects of peroxynitrite on human mitochondrial creatine kinase isoenzymes. Inactivation, octamer destabilization, and identification of involved residues J. Biol. Chem. 278 2003 1125 1130
129. S. Soboll, D. Brdiczka, D. Jahnke, A. Schmidt, U. Schlattner, S. Wendt, M. Wyss, and T. Wallimann Octamer-dimer transitions of mitochondrial creatine kinase in heart disease J. Mol. Cell. Cardiol. 31 1999 857 866
130. M. Tokarska-Schlattner, M. Zaugg, R. da Silva, E. Lucchinetti, M.C. Schaub, T. Wallimann, and U. Schlattner Acute toxicity of doxorubicin on isolated perfused heart: response of kinases regulating energy supply Am. J. Physiol.: Heart Circ. Physiol. 289 2005 H37 H47
131. A. Kaasik, A. Minajeva, E. De Sousa, R. Ventura-Clapier, and V. Veksler Nitric oxide inhibits cardiac energy production via inhibition of mitochondrial creatine kinase FEBS Lett. 444 1999 75 77
132. G. Yuan, M. Kaneko, H. Masuda, R.B. Hon, A. Kobayashi, and N. Yamazaki Decrease in heart mitochondrial creatine kinase activity due to oxygen free radicals Biochim. Biophys. Acta 1140 1992 78 84
133. T. Miura, S. Muraoka, and T. Ogiso Adriamycin-Fe(3+)-induced inactivation of rat heart mitochondrial creatine kinase: sensitivity to lipid peroxidation Biol. Pharm. Bull. 17 1994 1220 1223
134. A. Denicola, H. Rubbo, D. Rodriguez, and R. Radi Peroxynitrite-mediated cytotoxicity to Trypanosoma cruzi Arch. Biochem. Biophys. 304 1993 279 286
135. B. Font, C. Vial, D. Goldschmidt, D. Eichenberger, and D.C. Gautheron Effects of SH group reagents on creatine kinase interaction with the mitochondrial membrane Arch. Biochem. Biophys. 220 1983 541 548
136. M.J. Vacheron, E. Clottes, C. Chautard, and C. Vial Mitochondrial creatine kinase interaction with phospholipid vesicles Arch. Biochem. Biophys. 344 1997 316 324
137. R. Furter, E.M. Furter-Graves, and T. Wallimann Creatine kinase: the reactive cysteine is required for synergism but is nonessential for catalysis Biochemistry 32 1993 7022 7029
138. M. Gross, and T. Wallimann Dimer-dimer interactions in octameric mitochondrial creatine kinase Biochemistry 34 1995 6660 6667
139. M. Gross, E.M. Furter-Graves, T. Wallimann, H.M. Eppenberger, and R. Furter The tryptophan residues of mitochondrial creatine kinase: roles of Trp-223, Trp-206, and Trp-264 in active-site and quaternary structure formation Protein Sci. 3 1994 1058 1068
140. P.W. Hochachka The metabolic implications of intracellular circulation Proc. Natl. Acad. Sci. U. S. A. 96 1999 12233 12239
141. M. Spindler, R. Niebler, H. Remkes, M. Horn, T. Lanz, and S. Neubauer Mitochondrial creatine kinase is critically necessary for normal myocardial high-energy phosphate metabolism Am. J. Physiol.: Heart Circ. Physiol. 283 2002 H680 H687
142. M. Wyss, J. Smeitink, R.A. Wevers, and T. Wallimann Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism Biochim. Biophys. Acta 1102 1992 119 166
143. B. Crozatier, T. Badoual, E. Boehm, P.V. Ennezat, T. Guenoun, J. Su, V. Veksler, L. Hittinger, and R. Ventura-Clapier Role of creatine kinase in cardiac excitation-contraction coupling: studies in creatine kinase-deficient mice FASEB J. 16 2002 653 660
144. M. Spindler, K. Meyer, H. Stromer, A. Leupold, E. Boehm, H. Wagner, and S. Neubauer Creatine kinase-deficient hearts exhibit increased susceptibility to ischemia-reperfusion injury and impaired calcium homeostasis Am. J. Physiol.: Heart Circ. Physiol. 287 2004 H1039 H1045
145. M. Nahrendorf, M. Spindler, K. Hu, L. Bauer, O. Ritter, P. Nordbeck, T. Quaschning, K.H. Hiller, J. Wallis, G. Ertl, W.R. Bauer, and S. Neubauer Creatine kinase knockout mice show left ventricular hypertrophy and dilatation, but unaltered remodeling post-myocardial infarction Cardiovasc. Res. 65 2005 419 427
146. R. Liao, L. Nascimben, J. Friedrich, J.K. Gwathmey, and J.S. Ingwall Decreased energy reserve in an animal model of dilated cardiomyopathy, relationship to contractile performance Circ. Res. 78 1996 893 902
147. W.L. Gross, M.I. Bak, J.S. Ingwall, M.A. Arstall, T.W. Smith, J.L. Ballig, and R.A. Kelly Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve Proc. Natl. Acad. Sci. U. S. A. 93 1996 5604 5609
148. J.S. Ingwall, and R.G. Weiss Is the failing heart energy starved? On using chemical energy to support cardiac function Circ. Res. 95 2004 135 145
149. M. ten Hove, C.A. Lygate, A. Fischer, J.E. Schneider, A.E. Sang, K. Hulbert, L. Sebag-Montefiore, H. Watkins, K. Clarke, D. Isbrandt, J. Wallis, and S. Neubauer Reduced inotropic reserve and increased susceptibility to cardiac ischemia/reperfusion injury in phosphocreatine-deficient guanidinoacetate-N- methyltransferase-knockout mice Circulation 111 2005 2477 2485
150. N. Kaul, N. Siveski-Iliskovic, M. Hill, J. Slezak, and P.K. Singal Free radicals and the heart J. Pharmacol. Toxicol. Methods 30 1993 55 67
151. J.P. Kehrer Free radicals as mediators of tissue injury and disease Crit. Rev. Toxicol. 23 1993 21 48
152. J.M. McCord, and W.J. Russell Inactivation of creatine phosphokinase by superoxide during reperfusion injury Basic Life Sci. 49 1988 869 873
153. L. Kay, V.A. Saks, and A. Rossi Early alteration of the control of mitochondrial function in myocardial ischemia J. Mol. Cell. Cardiol. 29 1997 3399 3411
154. P. Dos Santos, M.N. Laclau, S. Boudina, and K.D. Garlid Alterations of the bioenergetics systems of the cell in acute and chronic myocardial ischemia Mol. Cell. Biochem. 256-257 2004 157 166
155. P. Korge, S.K. Byrd, and K.B. Campbell Functional coupling between sarcoplasmic-reticulum-bound creatine kinase and Ca(2+)-ATPase Eur. J. Biochem. 213 1993 973 980
156. A. Minajeva, R. Ventura-Clapier, and V. Veksler Ca2+ uptake by cardiac sarcoplasmic reticulum ATPase in situ strongly depends on bound creatine kinase Pflugers Arch. 432 1996 904 912
157. A.M. Rossi, H.M. Eppenberger, P. Volpe, R. Cotrufo, and T. Wallimann Muscle-type MM creatine kinase is specifically bound to sarcoplasmic reticulum and can support Ca2+ uptake and regulate local ATP/ADP ratios J. Biol. Chem. 265 1990 5258 5266
158. B.L. Hamman, J.A. Bittl, W.E. Jacobus, P.D. Allen, R.S. Spencer, R. Tian, and J.S. Ingwall Inhibition of the creatine kinase reaction decreases the contractile reserve of isolated rat hearts Am. J. Physiol. 269 1995 H1030 H1036
159. M. Zaugg, and M.C. Schaub Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning J. Muscle Res. Cell Motil. 24 2003 219 249
160. D. Pucar, P.P. Dzeja, P. Bast, N. Juranic, S. Macura, and A. Terzic Cellular energetics in the preconditioned state: protective role for phosphotransfer reactions captured by 18O-assisted 31P NMR J. Biol. Chem. 276 2001 44812 44819
161. M.N. Laclau, S. Boudina, J.B. Thambo, L. Tariosse, G. Gouverneur, S. Bonoron-Adele, V.A. Saks, K.D. Garlid, and P. Dos Santos Cardioprotection by ischemic preconditioning preserves mitochondrial function and functional coupling between adenine nucleotide translocase and creatine kinase J. Mol. Cell. Cardiol. 33 2001 947 956
162. J. Zhang Myocardial energetics in cardiac hypertrophy Clin. Exp. Pharmacol. Physiol. 29 2002 351 359
163. R. Ventura-Clapier, A. Garnier, and V. Veksler Energy metabolism in heart failure J. Physiol. 555 2004 1 13
164. K.W. Saupe, M. Spindler, R. Tian, and J.S. Ingwall Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase Circ. Res. 82 1998 898 907
165. M. Spindler, S. Engelhardt, R. Niebler, H. Wagner, L. Hein, M.J. Lohse, and S. Neubauer Alterations in the myocardial creatine kinase system precede the development of contractile dysfunction in beta(1)-adrenergic receptor transgenic mice J. Mol. Cell. Cardiol. 35 2003 389 397
166. Y.M. Cha, P.P. Dzeja, W.K. Shen, A. Jahangir, C.Y. Hart, A. Terzic, and M.M. Redfield Failing atrial myocardium: energetic deficits accompany structural remodeling and electrical instability Am. J. Physiol.: Heart Circ. Physiol. 284 2003 H1313 H1320
167. Y. Ye, G. Gong, K. Ochiai, J. Liu, and J. Zhang High-energy phosphate metabolism and creatine kinase in failing hearts: a new porcine model Circulation 103 2001 1570 1576
168. E. De Sousa, V. Veksler, A. Minajeva, A. Kaasik, P. Mateo, E. Mayoux, J. Hoerter, X. Bigard, B. Serrurier, and R. Ventura-Clapier Subcellular creatine kinase alterations. Implications in heart failure Circ. Res. 85 1999 68 76
169. G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, and L. Gianni Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity Pharmacol. Rev. 56 2004 185 229
170. R.D. Olson, and P.S. Mushlin Doxorubicin cardiotoxicity: analysis of prevailing hypotheses FASEB J. 4 1990 3076 3086
171. P.K. Singal, N. Iliskovic, T. Li, and D. Kumar Adriamycin cardiomyopathy: pathophysiology and prevention FASEB J. 11 1997 931 936
172. K. Nicolay, W.P. Aue, J. Seelig, C.J. van Echteld, T.J. Ruigrok, and B. de Kruijff Effects of the anti-cancer drug adriamycin on the energy metabolism of rat heart as measured by in vivo 31P-NMR and implications for adriamycin-induced cardiotoxicity Biochim. Biophys. Acta 929 1987 5 13
173. A.B. Eidenschink, G. Schroter, S. Muller-Weihrich, and H. Stern Myocardial high-energy phosphate metabolism is altered after treatment with anthracycline in childhood Cardiol. Young 10 2000 610 617
174. M. Tokarska-Schlattner, T. Wallimann, U. Schlattner, Alterations in myocardial energetics induced by the anti-cancer drug doxorubicin, CR Biol. (in press).
175. D. Cheneval, E. Carafoli, G.L. Powell, and D. Marsh A spin-label electron spin resonance study of the binding of mitochondrial creatine kinase to cardiolipin Eur. J. Biochem. 186 1989 415 419
176. E. Goormaghtigh, P. Chatelain, J. Caspers, and J.M. Ruysschaert Evidence of a specific complex between adriamycin and negatively-charged phospholipids Biochim. Biophys. Acta 597 1980 1 14
177. K. Nicolay, J.J. Fok, W. Voorhout, J.A. Post, and B. de Kruijff Cytofluorescence detection of adriamycin-mitochondria interactions in isolated, perfused rat heart Biochim. Biophys. Acta 887 1986 35 41
178. P.M. Sokolove Interactions of adriamycin aglycones with mitochondria may mediate adriamycin cardiotoxicity Int. J. Biochem. 26 1994 1341 1350
179. M. Muller, R. Moser, D. Cheneval, and E. Carafoli Cardiolipin is the membrane receptor for mitochondrial creatine phosphokinase J. Biol. Chem. 260 1985 3839 3843
180. G. Minotti, G. Cairo, and E. Monti Role of iron in anthracycline cardiotoxicity: new tunes for an old song? FASEB J. 13 1999 199 212
181. D.M. Weinstein, M.J. Mihm, and J.A. Bauer Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice J. Pharmacol. Exp. Ther. 294 2000 396 401
182. D.A. Gewirtz A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin Biochem. Pharmacol. 57 1999 727 741
183. R. Jeyaseelan, C. Poizat, H.Y. Wu, and L. Kedes Molecular mechanisms of doxorubicin-induced cardiomyopathy. Selective suppression of Reiske iron-sulfur protein, ADP/ATP translocase, and phosphofructokinase genes is associated with ATP depletion in rat cardiomyocytes J. Biol. Chem. 272 1997 5828 5832
184. S. Zhou, A. Starkov, M.K. Froberg, R.L. Leino, and K.B. Wallace Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin Cancer Res. 61 2001 771 777
185. K. Nicolay, R.J. Timmers, E. Spoelstra, R. Van der Neut, J.J. Fok, Y.M. Huigen, A.J. Verkleij, and B. De Kruijff The interaction of adriamycin with cardiolipin in model and rat liver mitochondrial membranes Biochim. Biophys. Acta 778 1984 359 371
186. M. Eder, K. Fritz-Wolf, W. Kabsch, T. Wallimann, and U. Schlattner Crystal structure of human ubiquitous mitochondrial creatine kinase Proteins 39 2000 216 225
187. L.C. Papadopoulou, G. Theophilidis, G.N. Thomopoulos, and A.S. Tsiftsoglou Structural and functional impairment of mitochondria in adriamycin-induced cardiomyopathy in mice: suppression of cytochrome c oxidase II gene expression Biochem. Pharmacol. 57 1999 481 489
188. H.C. Yen, T.D. Oberley, C.G. Gairola, L.I. Szweda, and D.K. St. Clair Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice Arch. Biochem. Biophys. 362 1999 59 66
189. T. Kekelidze, I. Khait, A. Togliatti, J.M. Benzecry, B. Wieringa, and D. Holtzman Altered brain phosphocreatine and ATP regulation when mitochondrial creatine kinase is absent J. Neurosci. Res. 66 2001 866 872
190. S. David, M. Shoemaker, and B.E. Haley Abnormal properties of creatine kinase in Alzheimer's disease brain: correlation of reduced enzyme activity and active site photolabeling with aberrant cytosol-membrane partitioning Brain Res. Mol. Brain Res. 54 1998 276 287
191. A.Z. Haghighi, and K.R. Maples On the mechanism of the inhibition of glutamine synthetase and creatine phosphokinase by methionine sulfoxide J. Neurosci. Res. 43 1996 107 111
192. S. Wendt, A. Dedeoglu, O. Speer, T. Wallimann, M.F. Beal, and O.A. Andreassen Reduced creatine kinase activity in transgenic amyotrophic lateral sclerosis mice Free Radical Biol. Med. 32 2002 920 926
193. S. Wendt, A. Dedeoglu, O. Speer, T. Wallimann, M.F. Beal, and O.A. Andreassen Reduced creatine kinase activity in transgenic amyotrophic lateral sclerosis mice Free Radical Biol. Med. 32 2002 920 926
194. M.C. Walter, H. Lochmuller, P. Reilich, T. Klopstock, R. Huber, M. Hartard, M. Hennig, D. Pongratz, and W. Muller-Felber Creatine monohydrate in muscular dystrophies: a double-blind, placebo-controlled clinical study Neurology 54 2000 1848 1850
195. S. Felber, D. Skladal, M. Wyss, C. Kremser, A. Koller, and W. Sperl Oral creatine supplementation in Duchenne muscular dystrophy: a clinical and 31P magnetic resonance spectroscopy study Neurol. Res. 22 2000 145 150
196. M.A. Tarnopolsky, D.J. Mahoney, J. Vajsar, C. Rodriguez, T.J. Doherty, B.D. Roy, and D. Biggar Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy Neurology 62 2004 1771 1777
197. M.A. Tarnopolsky, B.D. Roy, and J.R. MacDonald A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies Muscle Nerve 20 1997 1502 1509
198. M. Vorgerd, J. Zange, R. Kley, T. Grehl, A. Husing, M. Jager, K. Muller, R. Schroder, W. Mortier, K. Fabian, J.P. Malin, and A. Luttmann Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study Arch. Neurol. 59 2002 97 101
199. P. Klivenyi, R.J. Ferrante, R.T. Matthews, M.B. Bogdanov, A.M. Klein, O.A. Andreassen, G. Mueller, M. Wermer, R. Kaddurah-Daouk, and M.F. Beal Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis Nat. Med. 5 1999 347 350
200. O.A. Andreassen, B.G. Jenkins, A. Dedeoglu, K.L. Ferrante, M.B. Bogdanov, R. Kaddurah-Daouk, and M.F. Beal Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation J. Neurochem. 77 2001 383 390
201. P. Klivenyi, M. Kiaei, G. Gardian, N.Y. Calingasan, and M.F. Beal Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis J. Neurochem. 88 2004 576 582
202. O.A. Andreassen, A. Dedeoglu, R.J. Ferrante, B.G. Jenkins, K.L. Ferrante, M. Thomas, A. Friedlich, S.E. Browne, G. Schilling, D.R. Borchelt, S.M. Hersch, C.A. Ross, and M.F. Beal Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease Neurobiol. Dis. 8 2001 479 491
203. A. Dedeoglu, J.K. Kubilus, L. Yang, K.L. Ferrante, S.M. Hersch, M.F. Beal, and R.J. Ferrante Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice J. Neurochem. 85 2003 1359 1367
204. R.T. Matthews, R.J. Ferrante, P. Klivenyi, L. Yang, A.M. Klein, G. Mueller, R. Kaddurah-Daouk, and M.F. Beal Creatine and cyclocreatine attenuate MPTP neurotoxicity Exp. Neurol. 157 1999 142 149
205. P. Klivenyi, G. Gardian, N.Y. Calingasan, L. Yang, and M.F. Beal Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease J. Mol. Neurosci. 21 2003 191 198
206. K.H. Adcock, J. Nedelcu, T. Loenneker, E. Martin, T. Wallimann, and B.P. Wagner Neuroprotection of creatine supplementation in neonatal rats with transient cerebral hypoxia-ischemia Dev. Neurosci. 24 2002 382 388
207. S. Zhu, M. Li, B.E. Figueroa, A. Liu, I.G. Stavrovskaya, P. Pasinelli, M.F. Beal, R.H. Brown Jr., B.S. Kristal, R.J. Ferrante, and R.M. Friedlander Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice J. Neurosci. 24 2004 5909 5912
208. P. Klivenyi, N.Y. Calingasan, A. Starkov, I.G. Stavrovskaya, B.S. Kristal, L. Yang, B. Wieringa, and M.F. Beal Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase Neurobiol. Dis. 15 2004 610 617
209. D.C. Turner, R. Gmur, H.G. Lebherz, M. Siegrist, T. Wallimann, and H.M. Eppenberger Differentiation in cultures derived from embryonic chicken muscle: II. Phosphorylase histochemistry and fluorescent antibody staining for creatin kinase and aldolase Dev. Biol. 48 1976 284 307
210. T. Schmitt, and D. Pette Increased mitochondrial creatine kinase in chronically stimulated fast-twitch rabbit muscle FEBS Lett. 188 1985 341 344
211. F.S. Apple, M.A. Rogers, W.M. Sherman, D.L. Costill, F.C. Hagerman, and J.L. Ivy Profile of creatine kinase isoenzymes in skeletal muscles of marathon runners Clin. Chem. 30 1984 413 416
212. E. O'Gorman, G. Beutner, T. Wallimann, and D. Brdiczka Differential effects of creatine depletion on the regulation of enzyme activities and on creatine-stimulated mitochondrial respiration in skeletal muscle, heart, and brain Biochim. Biophys. Acta 1276 1996 161 170
213. R.J. Wiesner, T.V. Hornung, J.D. Garman, D.A. Clayton, E. O'Gorman, and T. Wallimann Stimulation of mitochondrial gene expression and proliferation of mitochondria following impairment of cellular energy transfer by inhibition of the phosphocreatine circuit in rat hearts J. Bioenerg. Biomembr. 31 1999 559 567
214. A.M. Stadhouders, P.H. Jap, H.P. Winkler, H.M. Eppenberger, and T. Wallimann Mitochondrial creatine kinase: a major constituent of pathological inclusions seen in mitochondrial myopathies Proc. Natl. Acad. Sci. U. S. A. 91 1994 5089 5093
215. X.H. Liu, L.J. Qian, J.B. Gong, J. Shen, X.M. Zhang, and X.H. Qian Proteomic analysis of mitochondrial proteins in cardiomyocytes from chronic stressed rat Proteomics 4 2004 3167 3176
216. C.K. Lee, R.G. Klopp, R. Weindruch, and T.A. Prolla Gene expression profile of aging and its retardation by caloric restriction Science 285 1999 1390 1393
217. V. Hanzlikova, and S. Schiaffino Mitochondrial changes in ischemic skeletal muscle J. Ultrastruct. Res. 60 1977 121 133
218. Z. Gori, V. De Tata, M. Pollera, and E. Bergamini Mitochondrial myopathy in rats fed with a diet containing beta-guanidine propionic acid, an inhibitor of creatine entry in muscle cells Br. J. Exp. Pathol. 69 1988 639 650
219. Y. Ohira, M. Kanzaki, and C.S. Chen Intramitochondrial inclusions caused by depletion of creatine in rat skeletal muscles Jpn. J. Physiol. 38 1988 159 166
220. V. De Tata, G. Cavallini, M. Pollera, Z. Gori, and E. Bergamini The induction of mitochondrial myopathy in the rat by feeding beta- guanidinopropionic acid and the reversibility of the induced mitochondrial lesions: a biochemical and ultrastructural investigation Int. J. Exp. Pathol. 74 1993 501 509
221. M. Eppenberger-Eberhardt, I. Riesinger, M. Messerli, P. Schwarb, M. Muller, H.M. Eppenberger, and T. Wallimann Adult rat cardiomyocytes cultured in creatine-deficient medium display large mitochondria with paracrystalline inclusions, enriched for creatine kinase J. Cell Biol. 113 1991 289 302
222. J. van Deursen, P. Jap, A. Heerschap, H. ter Laak, W. Ruitenbeek, and B. Wieringa Effects of the creatine analogue beta-guanidinopropionic acid on skeletal muscles of mice deficient in muscle creatine kinase Biochim. Biophys. Acta 1185 1994 327 335
223. E.A. Boehm, G.K. Radda, H. Tomlin, and J.F. Clark The utilisation of creatine and its analogues by cytosolic and mitochondrial creatine kinase Biochim. Biophys. Acta 1274 1996 119 128
224. D. Holtzman, E. McFarland, T. Moerland, J. Koutcher, M.J. Kushmerick, and L.J. Neuringer Brain creatine phosphate and creatine kinase in mice fed an analogue of creatine Brain Res. 483 1989 68 77
225. H. Mekhfi, J. Hoerter, C. Lauer, C. Wisnewsky, K. Schwartz, and R. Ventura-Clapier Myocardial adaptation to creatine deficiency in rats fed with beta-guanidinopropionic acid, a creatine analogue Am. J. Physiol. 258 1990 H1151 H1158
226. E. O'Gorman, K.H. Fuchs, P. Tittmann, H. Gross, and T. Wallimann Crystalline mitochondrial inclusion bodies isolated from creatine depleted rat soleus muscle J. Cell Sci. 110 1997 1403 1411
227. O. Stachowiak, U. Schlattner, M. Dolder, and T. Wallimann Oligomeric state and membrane binding behaviour of creatine kinase isoenzymes: implications for cellular function and mitochondrial structure Mol. Cell. Biochem. 184 1998 141 151
228. S. DiMauro, E. Bonilla, M. Zeviani, M. Nakagawa, and D.C. DeVivo Mitochondrial myopathies Ann. Neurol. 17 1985 521 538
229. D.C. Wallace Mitochondrial DNA mutations and neuromuscular disease Trends Genet. 5 1989 9 13
230. E.A. Schon Mitochondrial genetics and disease Trends Biochem. Sci. 25 2000 555 560
231. A. Heddi, G. Stepien, P.J. Benke, and D.C. Wallace Coordinate induction of energy gene expression in tissues of mitochondrial disease patients J. Biol. Chem. 274 1999 22968 22976
232. J. Smeitink, A. Stadhouders, R. Sengers, W. Ruitenbeek, R. Wevers, H. ter Laak, and F. Trijbels Mitochondrial creatine kinase containing crystals, creatine content and mitochondrial creatine kinase activity in chronic progressive external ophthalmoplegia Neuromuscular Disord. 2 1992 35 40
233. A.M. Stadhouders, and R.C. Sengers Morphological observations in skeletal muscle from patients with a mitochondrial myopathy J. Inherited Metab. Dis. 1 1987 62 80
234. A. Malandrini, F. Albani, S. Palmeri, F. Fattapposta, S. Gambelli, G. Berti, A. Bracco, A. Tammaro, S. Calzavara, M. Villanova, M. Ferrari, A. Rossi, and P. Carrera Asymptomatic cores and paracrystalline mitochondrial inclusions in CADASIL Neurology 59 2002 617 620
235. G.W. Farrants, S. Hovmoller, and A.M. Stadhouders Two types of mitochondrial crystals in diseased human skeletal muscle fibers Muscle Nerve 11 1988 45 55
236. E.J. Cupler, M.J. Danon, C. Jay, K. Hench, M. Ropka, and M.C. Dalakas Early features of zidovudine-associated myopathy: histopathological findings and clinical correlations Acta Neuropathol. (Berl.) 90 1995 1 6
237. E. O'Gorman, T. Piendl, M. Muller, D. Brdiczka, and T. Wallimann Mitochondrial intermembrane inclusion bodies: the common denominator between human mitochondrial myopathies and creatine depletion, due to impairment of cellular energetics Mol. Cell. Biochem. 174 1997 283 289
238. T. Wallimann, M. Dolder, U. Schlattner, M. Eder, T. Hornemann, E. O'Gorman, A. Ruck, and D. Brdiczka Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology BioFactors 8 1998 229 234
239. M.A. Tarnopolsky, D.K. Simon, B.D. Roy, K. Chorneyko, S.A. Lowther, D.R. Johns, J.K. Sandhu, Y. Li, and M. Sikorska Attenuation of free radical production and paracrystalline inclusions by creatine supplementation in a patient with a novel cytochrome b mutation Muscle Nerve 29 2004 537 547
240. A. Borchert, E. Wilichowski, and F. Hanefeld Supplementation with creatine monohydrate in children with mitochondrial encephalomyopathies Muscle Nerve 22 1999 1299 1300
241. T. Klopstock, V. Querner, F. Schmidt, F. Gekeler, M. Walter, M. Hartard, M. Henning, T. Gasser, D. Pongratz, A. Straube, M. Dieterich, and W. Muller-Felber A placebo-controlled crossover trial of creatine in mitochondrial diseases Neurology 55 2000 1748 1751
242. R. Pratt, L.M. Vallis, C.W. Lim, and W.N. Chisnall Mitochondrial creatine kinase in cancer patients Pathology 19 1987 162 165
243. M. DeLuca, N. Hall, R. Rice, and N.O. Kaplan Creatine kinase isozymes in human tumors Biochem. Biophys. Res. Commun. 99 1981 189 195
244. F. Kanemitsu, I. Kawanishi, J. Mizushima, and T. Okigaki Mitochondrial creatine kinase as a tumor-associated marker Clin. Chim. Acta 138 1984 175 183
245. M. Kornacker, U. Schlattner, T. Wallimann, M.R. Verneris, R.S. Negrin, B. Kornacker, A. Staratschek-Jox, V. Diehl, and J. Wolf Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis Int. J. Cancer 94 2001 513 519
246. C.V. Dang, and G.L. Semenza Oncogenic alterations of metabolism Trends Biochem. Sci. 24 1999 68 72
247. D. Holtzman, A. Togliatti, I. Khait, and F. Jensen Creatine increases survival and suppresses seizures in the hypoxic immature rat Pediatr. Res. 44 1998 410 414
248. A.J. Carter, R.E. Muller, U. Pschorn, and W. Stransky Preincubation with creatine enhances levels of creatine phosphate and prevents anoxic damage in rat hippocampal slices J. Neurochem. 64 1995 2691 2699
249. K. Miller, J. Halow, and A.P. Koretsky Phosphocreatine protects transgenic mouse liver expressing creatine kinase from hypoxia and ischemia Am. J. Physiol. 265 1993 C1544 C1551
250. E. Hatano, A. Tanaka, S. Iwata, S. Satoh, T. Kitai, S. Tsunekawa, T. Inomoto, H. Shinohara, B. Chance, and Y. Yamaoka Induction of endotoxin tolerance in transgenic mouse liver expressing creatine kinase Hepatology 24 1996 663 669
251. G. Bergnes, W. Yuan, V.S. Khandekar, M.M. O'Keefe, K.J. Martin, B.A. Teicher, and R. Kaddurah-Daouk Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis Oncol. Res. 8 1996 121 130
252. E.E. Miller, A.E. Evans, and M. Cohn Inhibition of rate of tumor growth by creatine and cyclocreatine Proc. Natl. Acad. Sci. U. S. A. 90 1993 3304 3308
253. C.A. Kristensen, N. Askenasy, R.K. Jain, and A.P. Koretsky Creatine and cyclocreatine treatment of human colon adenocarcinoma xenografts: 31P and 1H magnetic resonance spectroscopic studies Br. J. Cancer 79 1999 278 285
254. C. Brenner, and G. Kroemer Apoptosis. Mitochondria-The death signal integrators Science 289 2000 1150 1151